Healthcare organisations should run automated, recurring access reviews across EHR and connected systems, not rely on ad hoc checks. Reviews should cover employees, physicians, contractors, students, and vendors, then drive timely deprovisioning when access is no longer justified. The goal is to confirm legitimate need, catch inappropriate access early, and create a repeatable privacy control that scales with organisational growth.
Why periodic access reviews need to be structured around care delivery and privacy risk
In healthcare, the review cadence matters less than whether the review is tied to the systems and roles that can actually expose patient information. A useful structure starts with EHRs, revenue-cycle tools, portals, and connected clinical systems, then extends to contractors, students, vendors, and other non-employees whose access often persists beyond operational need. The review should test whether access still matches a current clinical, operational, or support need, not whether the account simply exists.
Access reviews work best when they are designed as a privacy control, not just a compliance ritual. That means reviewing both direct access and inherited access paths, checking whether role assignments still fit job function, and using the review to identify stale, excessive, or cross-functional access that could expose sensitive patient data. Teams that treat the review as a point-in-time approval often miss the real objective, which is to reduce unnecessary visibility into protected information.
Automation also matters because healthcare environments change constantly. New clinics, temporary staff, rotating trainees, outsourced support, and system integrations can expand access faster than manual review cycles can absorb. A repeatable process that pulls authoritative identity data, pre-populates reviewers with context, and routes removals into deprovisioning helps keep the control current. NHIMG’s Access Reviews and Certification Guide and Joiner-Mover-Leaver (JML) Guide both reinforce the point that review value depends on closure, not just attestation.
How to make the review population complete and the decisions defensible
The review population should reflect how healthcare actually operates. That usually means including employees, physicians, contractors, students, affiliated staff, third-party support, and any service identities that can reach patient data through applications, interfaces, or administrative consoles. If a population is excluded, the control may still look mature on paper while leaving a meaningful privacy gap in practice.
Each review decision should be anchored in evidence that a reviewer can validate quickly: current role, sponsoring department, system owner, business purpose, and whether the access is privileged, shared, or exceptional. When those details are missing, reviewers tend to rubber-stamp large lists or reject accounts without enough context. Good structure reduces review fatigue by limiting the number of items per reviewer and grouping access by meaningful business function rather than by raw technical entitlements. The same logic underpins identity governance more broadly in IAM and IGA Basics and the Identity Visibility and Intelligence Platforms (IVIP) Guide.
The most defensible programs also tie each decision to a clear remediation path. If access is no longer justified, removal should happen promptly and be traceable. If access is still needed but unusually broad, the result should be role correction, exception approval, or compensating control review rather than silent retention. That is especially important in healthcare, where overbroad access can persist for clinicians with changing privileges, vendor support personnel with broad emergency rights, or students and contractors whose sponsorship has changed.
What good looks like after the review closes the loop
A strong periodic review program does three things well: it finds excess access, removes it quickly, and produces evidence that the organisation can show to auditors, regulators, and privacy teams. The operational signal is not just that reviews were completed, but that findings led to measurable deprovisioning, role cleanup, or exception reduction. Reviews should be monitored for stale items, overdue certifications, and recurring approvals that suggest the underlying role model is too broad.
Over time, the program should improve the access baseline rather than merely repeating the same approvals. If the same accounts keep returning with the same issues, the problem is usually upstream in provisioning, role design, or ownership. That is why review outcomes should feed back into the identity lifecycle and role governance process. Supporting guidance on role clarity and entitlement hygiene is especially relevant in Role Mining and Role Design Guide, while Segregation of Duties (SoD) Guide is useful where patient data access overlaps with finance, billing, or privileged administrative functions.
The best programs also prove that exceptions are controlled rather than casually accepted. Temporary access should expire, sponsor ownership should be explicit, and terminated or transferred users should not remain active because the review process is treated as a yearly checklist. In practice, the control is strongest when it continuously shrinks unnecessary access, not when it merely documents that access existed.
Risk and Threat Considerations
Healthcare access reviews matter because the main failure mode is not a missed checkbox, but persistent inappropriate access to patient data. When reviews are infrequent, shallow, or too broad, stale accounts, excessive privileges, and unmanaged vendor access can remain in place long enough to create privacy exposure, insider misuse opportunities, and unnecessary blast radius after a credential compromise.
Failure mechanism: Reviewers approve access without enough context, exclude key populations, or fail to trigger timely deprovisioning, allowing unnecessary access to remain active across EHR and connected systems.
Impact: Patient information exposure increases, privacy investigations become harder, and an account compromise can reach more records than the business need would justify.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | AC-2 — Account Management | Periodic access reviews are core account lifecycle control for patient-data access. |
| AC-6 — Least Privilege | Healthcare access reviews should reduce excessive access to patient information. | |
| AU-6 — Audit Record Review, Analysis, and Reporting | Reviews depend on evidence from access and usage records to validate need and detect anomalies. | |
| Recommendation — Review accounts regularly and disable or remove access that no longer has a documented business need. Limit entitlements to the minimum required for each role and remove excess privileges during review. Correlate access review decisions with audit evidence to confirm access is justified and timely. | ||
| ISO/IEC 27001:2022 | A.5.18 — Access rights | Access reviews are the mechanism for confirming and removing continuing access rights. |
| A.5.15 — Access control | The question is about structuring control over who can access patient data. | |
| A.8.3 — Information access restriction | Healthcare privacy risk rises when access to patient records is not restricted to need-to-know. | |
| Recommendation — Recertify access rights on a set schedule and revoke rights that no longer align with business need. Define access review ownership, scope, and approval criteria for systems holding patient information. Apply need-to-know restrictions and verify them during periodic review. | ||
| CIS Controls v8 | CIS-5 — Account Management | Periodic review and deprovisioning are account management safeguards for privacy-sensitive systems. |
| CIS-6 — Access Control Management | The control question is how to structure access governance to prevent unnecessary patient-data exposure. | |
| Recommendation — Maintain account inventories and remove dormant or unjustified access promptly after each review cycle. Enforce least privilege and role-based access so reviewers can recertify smaller, more meaningful access sets. | ||
Practitioner Guidance
What to prioritise: Start with the systems and populations that can reach the broadest patient data sets, then move to privileged, vendor, and temporary-access cases. If a review queue is too large to inspect with context, the design is too coarse.
What to verify: Make sure every access decision can be traced to a current owner, a current business reason, and a defined removal path. If reviewers cannot validate those three items quickly, the review is not yet operationally reliable.
Practitioner takeaway: The real control is not the review event itself, but the combination of complete scope, reviewer context, and fast deprovisioning when access no longer matches legitimate need.
Related resources from NHI Mgmt Group
- When does event-driven IAM reduce risk more than periodic access reviews?
- Why do periodic access reviews fail to reduce identity risk in real environments?
- How should organisations run access reviews so they reduce risk instead of just meeting audit requirements?
- How should healthcare organisations reduce risk from vendor remote access?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 26, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
